Showing results (1491-1500 of 1,567) with videos related to

Sort By:
Pageof 157
IJID Regions|June 20, 2022
Covishield vaccine induces robust immune responses in Bangladeshi adultsTaufiqur Rahman Bhuiyan, Marjahan Akhtar, Fatema Khaton, et al.
Mymensingh Medical Journal : MMJ|November 9, 2012
Fasting glycaemic and lipidaemic status in acute coronary syndrome patients within 24 hours of onset of chest painM Tariquzzaman, S R Sutradhar, M F Haque, et al.
Pathogens (Basel, Switzerland)|December 22, 2023
Adherence to Anti-Malarial Treatment in Malaria Endemic Areas of BangladeshMohammad Sharif Hossain, Mohammad Abdul Matin, Nur-E Naznin Ferdous, et al.
Nature Communications|November 27, 2020
A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemiaKyle Spinler, Jeevisha Bajaj, Takahiro Ito, et al.
Chest|October 10, 2020
Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping ReviewAizhamal Tabyshova, John R Hurst, Joan B Soriano, et al.
IJID Regions|September 2, 2025
Assessing long-lasting insecticidal net coverage, access, and use: Insights from malaria-endemic regions and Rohingya camps in BangladeshMohammad Sharif Hossain, Amit Kumer Neogi, Ching Swe Phru, et al.
Molecular Oncology|April 15, 2014
Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1Victoria E Villegas, Mohammed Ferdous-Ur Rahman, Maite G Fernandez-Barrena, et al.
Frontiers in Psychiatry|May 3, 2021
Problematic Smartphone and Social Media Use Among Bangladeshi College and University Students Amid COVID-19: The Role of Psychological Well-Being and Pandemic Related FactorsMd Saiful Islam, Md Safaet Hossain Sujan, Rafia Tasnim, et al.
Vaccine|July 5, 2021
A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in BangladeshFahima Chowdhury, Khalid Ali Syed, Afroza Akter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 9, 2022
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trialShamir R Mehta, Guillaume Pare, Eva M Lonn, et al.
Pageof 157